An integrated analysis and comparison of serum, saliva and sebum for COVID-19 metabolomics.

Scientific reports 2022 Jul 13

filter terms:

The majority of metabolomics studies to date have utilised blood serum or plasma, biofluids that do not necessarily address the full range of patient pathologies. Here, correlations between serum metabolites, salivary metabolites and sebum lipids are studied for the first time. 83 COVID-19 positive and negative hospitalised participants provided blood serum alongside saliva and sebum samples for analysis by liquid chromatography mass spectrometry. Widespread alterations to serum-sebum lipid relationships were observed in COVID-19 positive participants versus negative controls. There was also a marked correlation between sebum lipids and the immunostimulatory hormone dehydroepiandrosterone sulphate in the COVID-19 positive cohort. The biofluids analysed herein were also compared in terms of their ability to differentiate COVID-19 positive participants from controls; serum performed best by multivariate analysis (sensitivity and specificity of 0.97), with the dominant changes in triglyceride and bile acid levels, concordant with other studies identifying dyslipidemia as a hallmark of COVID-19 infection. Sebum performed well (sensitivity 0.92; specificity 0.84), with saliva performing worst (sensitivity 0.78; specificity 0.83). These findings show that alterations to skin lipid profiles coincide with dyslipidaemia in serum. The work also signposts the potential for integrated biofluid analyses to provide insight into the whole-body atlas of pathophysiological conditions. © 2022. The Author(s).

Citation

Matt Spick, Holly-May Lewis, Cecile F Frampas, Katie Longman, Catia Costa, Alexander Stewart, Deborah Dunn-Walters, Danni Greener, George Evetts, Michael J Wilde, Eleanor Sinclair, Perdita E Barran, Debra J Skene, Melanie J Bailey. An integrated analysis and comparison of serum, saliva and sebum for COVID-19 metabolomics. Scientific reports. 2022 Jul 13;12(1):11867